The use of gonadotrophin-releasing hormone (GnRH) analogue in endometroid adenocarcinoma of the ovary: A case report and discussion

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 161, Issue 1, 2012, Pages 110-111

  Shafiee, Mohamad Nasir ^a   Shan, Lim Pei ^a   Ahmad, Shuhaila ^b   Idris, Nazimah ^b   Omar, Mohd Hashim ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; GONADORELIN DERIVATIVE;

ADULT; BLOOD LEVEL; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER RECURRENCE; CASE REPORT; CLIMACTERIUM; CONSERVATIVE TREATMENT; CYST; CYTOLOGY; DISEASE SEVERITY; DYSMENORRHEA; ECHOGRAPHY; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; EVISCERATION; FEMALE; HISTOLOGY; HORMONAL THERAPY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LETTER; MEDICAL HISTORY; NULLIPARA; OSTEOPENIA; OUTCOME ASSESSMENT; OVARY ADENOCARCINOMA; PERITONEAL FLUID; PRIORITY JOURNAL; TREATMENT REFUSAL;

EID: 84858074562     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2011.11.014     Document Type: Letter

References (5)

1. R. Yancik Ovarian cancer: age contrasts in incidence, histology, disease stage at diagnosis, and mortality Cancer 71 1993 517 523 (Pubitemid 23021245)
2. M. Nishida, K. Watanabe, and N. Sato Malignant transformation of ovarian endometriosis Gynecol Obstet Invest 50 2000 18 25
3. S.J. Wilkinson, A. Kucukmetin, and P. Cross Expression of gonadotrophin releasing hormone receptor I is a favorable prognostic factor in epithelial ovarian cancer Hum Pathol 39 8 2008 1197 1204
4. R.B. Scott Malignant changes in endometriosis Obstet Gynecol 2 1953 283 289
5. G. Emons, and A.V. Schally The use of luteinizing hormone releasing hormone agonists and antagonist in gynaecological cancers Hum Reprod 9 7 1994 1364 1379 (Pubitemid 24224014)